UMIN ID: UMIN000000578
Registered date:01/04/2007
Second-line and third-line treatment after unsuccessful H. pylori eradication
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | H. pylori infection |
| Date of first enrollment | 2004/12/01 |
| Target sample size | 300 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Second-line regimen lansoprazole 60mg 2x amoxicillin 1500mg 2x metronidazole 750mg 2x (500-250) Third-line regimen rabeprazole 40mg 4x amoxicillin 2000mg 4x gatifloxacin 400mg 1x |
Outcome(s)
| Primary Outcome | eradication rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 15years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | allergy to drugs stated in protocol or pregnncy |
Related Information
| Primary Sponsor | Department of Internal Medicine, Keio University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Internal Medicine, Keio University School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Toshihiro Nishizawa |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo Japan |
| Telephone | 03-3353-1211 |
| nisizawa@f7.so-net.ne.jp | |
| Affiliation | Keio University School of Medicine Department of Internal Medicine |
| scientific contact | |
| Name | Hidekazu Suzuki |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo Japan |
| Telephone | 03-3353-1211 |
| Affiliation | Keio University School of Medicine Department of Internal Medicine |